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Abstract
Purpose—Physical and psychological symptoms experienced by patients with advanced cancer 
influence their wellbeing; how patient and family caregivers' symptom distress influence each 
other's wellbeing is less understood. This study examined the influence of patient and caregiver 
symptom distress on their threat appraisals and self-efficacy to cope with cancer.
Methods—We conducted secondary analysis of baseline data from an RCT that enrolled patients 
with advanced cancer and their family caregivers (N=484 dyads). Structural equation modeling 
and the actor-partner interdependence mediation model (APIMeM) were used to examine two 
models: threat appraisals as a mediator of the relationship between symptom distress and 
individual and family-related self-efficacy; and, self-efficacy (individual and family dimensions) 
as mediators of the relationship between symptom distress and threat appraisals.
Results—Data suggest the self-efficacy mediation model was the preferred model. More patient 
and caregiver symptom distress was directly associated with their own lower self-efficacy and 
more threatening appraisals. Patient and caregiver individual self-efficacy also mediated the 
relationship between their own symptom distress and threat appraisals. There were also significant 
interdependent effects. More patient symptom distress was associated with less caregiver family-
related self-efficacy; and, more caregiver symptom distress was directly associated with more 
threatening patient appraisals.
Conclusions—Patient and caregiver symptom distress influenced their own, and in some cases 
each other's, cognitive appraisals. Limitations of this study include the use of cross-sectional data 
and assessments of individually-focused (vs. family-focused) threat appraisals. These findings 
highlight the need to consider the management of patient and caregiver symptoms during 
advanced cancer.
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A diagnosis of advanced cancer is a challenging life event for patients and their family 
caregivers. At advanced stages of disease, the goals of treatment are no longer curative [1] 
and patients and caregivers must navigate the complexities of a life-threatening disease. 
Stress and coping theory [2] suggests that patient and caregiver cognitive appraisals about 
the cancer experience are key contributors to their wellbeing. In this theoretical framework, 
primary appraisals are evaluations of the significance of the advanced cancer [3], such as the 
ways in which the cancer diagnosis threatens their lives and livelihood. Secondary appraisals 
are assessments of their ability to manage the consequences of the illness; that is, their self-
efficacy to cope with the cancer or caregiving situation [4]. Patient and caregiver cancer-
related appraisals have been associated with their use of coping strategies [5], life 
satisfaction [6], and, quality of life [7]. Nonetheless, a number of critical knowledge gaps 
remain. A potentially important but understudied area is how the experience of physical and 
psychological symptoms, by patients and caregivers alike, influence their cancer-related 
appraisals.
Patients with advanced cancer are often dealing simultaneously with side effects from cancer 
treatment and symptoms from the disease itself [8]. Commonly experienced symptoms 
include nausea, pain, and fatigue, all of which can have detrimental influences on wellbeing 
[9,10]. As a result, symptom control is a frequent desire of patients [11] and their caregivers 
who often help with symptom management [12,13]. Unmanaged symptoms may impair 
patients' functional and psychologial wellbeing and complicate the day-to-day support 
needed from family caregivers.
Caregivers' own symptom experience warrants attention because their physical and mental 
health has implications for their own wellbeing [14] and their ability to provide care [15,16]. 
As the prevalence of chronic diseases such as diabetes, heart disease, and arthritis increases 
with age [17], cancer caregivers, who tend to be older [18], are likely to also be managing 
symptoms related to their own health conditions. Unfortunately, the demands of caring for a 
loved one with advanced cancer may impede caregivers' ability to attend to their own 
symptom management [19,20].
Taken together, patients' and caregivers' experience of symptoms may make advanced cancer 
more daunting and threatening (i.e. primary appraisal). In addition, these symptoms may 
negatively influence their self-efficacy to deal with the challenges of advanced cancer and 
caregiving (secondary appraisals). As part of a family, patients and caregivers often have 
concerns about how other members of the family are handling the illness [21,22]. Thus, it is 
useful to consider two related but distinct dimensions of self-efficacy to capture the range of 
secondary appraisals made by patients and caregivers: patients' and caregivers' own self-
efficacy to cope with cancer/caregiving (individual self-efficacy) and self-efficacy to help 
other family members manage cancer-related issues (family-related self-efficacy).
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Purpose & Aims
This study examines the influence of patient and caregiver symptom distress, as a significant 
stressor in their cancer experience, on their threat appraisals and their self-efficacy to cope 
with cancer (among patients) and the demands of cancer caregiving (among caregivers). 
Despite the ordinal naming of the concepts, stress and coping theory does not propose that a 
stressor (i.e., symptom distress) influences appraisal processes in a temporal fashion [2]. 
Previous research found that as patient and caregiver self-efficacy (i.e. secondary appraisal) 
for coping with cancer/caregiving increased, their negative illness-related appraisals (i.e. 
primary appraisal) decreased [7]. It is possible that the reverse relationship also exists. That 
is, patient and caregiver threat appraisals could influence their self-efficacy to cope with 
disease. Research suggests that in situations where the stressor is likely to be threatening and 
a source of significant strain, such as with advanced cancer, threat appraisals may have a 
significant influence on an individual's self-efficacy about their ability to cope with the 
illness and its consequences [23]. Moreover, how symptom distress might influence this 
relationship between self-efficacy and threat appraisals among patient-caregiver dyads in 
advanced cancer has not been explored.
Thus, in this study, two competing models will be tested: a threat mediated model, which 
examines threat appraisal as a mediator of the relationship between symptom distress and 
self-efficacy (Figure 1); and, an efficacy mediated model, which examines self-efficacy as a 
mediator of the relationship between symptom distress and threat appraisal (Figure 2). The 
interdependent nature of the patient-caregiver relationship during the advanced cancer stage 
suggests that patient and caregiver symptom distress and cognitive appraisals may be 
interrelated [24,25]. As a result, this study explores independent effects (i.e., how an 
individual's symptom distress influences their own appraisals) and interdependent effects 
(i.e., how an individual's symptom distress influences the other person's appraisals). Our 
hypotheses are as follows:
H1: Symptom distress reported by patients and caregivers will be positively 
associated with their own threat appraisals and the threat appraisals of the other 
member of the dyad.
H2: Symptom distress reported by patients and caregivers will be negatively 
associated with their own self-efficacy (individual and family-related) and the 
self-efficacy of the other member of the dyad.
H3: a) In the threat mediated model, threat appraisals reported by patients and 
caregivers will be negatively associated with their own self-efficacy (individual 
and family-related) and the other member of the dyad.
b) In the efficacy mediated model, self-efficacy reported by patients and 
caregivers will be negatively associated with their own threat appraisals and the 
threat appraisals of the other member of the dyad.
H4: a) In the threat mediated model, symptom distress will have a negative indirect 
effect on self-efficacy (mediated by threat appraisals).
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b) In the efficacy mediated model, symptom distress will have a positive 
indirect effect on threat appraisals (mediated by self-efficacy).
Method
Study Design
Data came from a randomized clinical trial (RCT) for patients with advanced cancer and 
their family caregivers that tested the efficacy of the evidence-based FOCUS program. Data 
were collected in the home by research staff who were blinded to the RCT group 
assignments of dyads. Patients and caregivers completed their questionnaires separately, 
without consulting each other, while a research staff member was present in the home. Our 
current analysis used baseline data. Detailed information related to the RCT procedures and 
study outcomes have been published elsewhere [26]. Institutional Review Board approval 
was obtained from the patient's cancer center and the University of Michigan (coordinating 
site).
Participants
The study sample included patients with advanced cancer and their family caregivers 
(N=484 dyads). All patients: were age 21 or older; had a confirmed diagnosis of advanced 
breast, colon, lung or prostate cancer and were within 6 months of the diagnosis, progression 
of their cancer, or a change of treatment for it; and, had a life expectancy of at least 6 months 
(as assessed by a physician). Patients diagnosed with multiple primary cancer sites were 
excluded from the study. The percentages of advanced cancers reported by patients were as 
follows: 32.4% breast cancer; 29.1% lung cancer; 25.4% colorectal cancer; and, 13.0% 
prostate cancer. A majority of patients were undergoing chemotherapy treatment (68.8%). 
Patients also reported receiving hormone therapy (16.5%), radiation therapy (8.3%), 
watchful waiting (7.6%), surgical treatment (2.9%) or another treatment not specified (5.4%) 
at baseline. Multiple responses for treatment were possible.
A family caregiver was defined as “the family member or significant other identified by the 
patient as his or her primary source of physical or emotional support during the advanced 
phase of cancer and confirmed by the designated individual” [26]. Family caregivers were 
age 18 or older and were excluded from the study if they had been diagnosed with cancer 
during the previous year and/or were in active treatment for cancer.
Patient and caregiver demographic information is presented in Table 1. The average age of 
patients was 60.5 years (SD: 11.5; range: 26–95) and of caregivers were 56.5 years (SD: 
13.4; range: 18–88). Most patients (62%) and caregivers (56.8%) were female. Patients and 
caregivers were predominantly White (approximately 80%). A majority of patients (75.6%) 
and caregivers (82.9%) were married or living as married and 70% were in a marital 
relationship with each other.
Instruments
Symptom distress—The 16-item Symptom Scale of the Risk for Distress Scale (patients: 
α = .74; caregivers: α = .89) was used to assess patient and caregiver physical and 
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psychological symptom distress [27,28]. Patients reported on the trouble experienced 
because of their cancer related and non-cancer symptoms during the past week; caregivers 
reported on the trouble experienced because of their own symptoms during the past week. 
Descriptive response options were appropriate for the symptoms and generally represented: 
0) no trouble, 1) some, and, 2) a lot. The z-scored total scale score was used in the analysis 
to standardize the items, with higher scores indicating higher symptom distress.
Threat appraisal—Threat appraisals were assessed with the 11-item subscale of the 
Appraisal of Illness Scale (patients: α = .90) and a corresponding 11-item subscale of the 
Appraisal of Caregiving Scale (caregivers: α =.89) [29–31]. Respondents answered 
questions based upon how they felt “over the last week including today.” An example item is 
“This situation threatens to overwhelm me.” Both instruments have a 5-point response scale 
ranging from “strongly disagree” to “strongly agree.” The total subscale score was used in 
the analysis with higher scores indicating higher threat appraisals.
Self-efficacy—Self-efficacy to manage the impact of the illness was measured using two-
subscales from the shorter version of the CASE Scale [32]. The 11-item individual self-
efficacy subscale measured patient/caregiver confidence in their ability to manage the 
general impact of cancer on themselves (patients: α = .96; caregivers: α = .95). An example 
item from this subscale is “I am confident that I can put the cancer into proper perspective in 
my life.” The 4-item family-related self-efficacy subscale measured patient/caregiver 
confidence in their ability to manage the impact of cancer on their family (patients: α = .94; 
caregivers: α = .91). An example item from this subscale is “I am confident that I have what 
it takes to help my family through the illness.” Responses were on a 10-point scale ranging 
from 0 (not at all confident) to 10 (very confident). The total subscale scores were used in 
the analysis with higher scores indicating higher self-efficacy.
Covariates—There are a number of demographic and medical factors which may influence 
relationships between patient and caregiver symptom distress and appraisal processes in 
advanced cancer. For example, younger age, lower income and female has been associated 
with more negative appraisals [33,34] and differences in appraisals have been seen by 
caregiver relationship type [33] as well as cancer type and time since diagnosis [35]. Age, 
sex, income, patient cancer type, patient treatment (chemotherapy vs. other; hormone 
therapy vs. other), length of time since patient diagnosis, living arrangements (living 
together vs. other), and the relationship between patient and caregiver (spouse vs. other) 
were obtained from patient medical records and the self-administered Risk for Distress 
Scale, which was adapted from the original Omega Clinic Screening Interview [26–28].
Data Analysis Strategy
The hypotheses were examined using the actor-partner interdependence mediation model or 
APIMeM [36]. This model consists of three pairs of variables corresponding to each dyad 
member: predictor variables (symptom distress); mediator variables (threat appraisals); and, 
outcome variables (self-efficacy). Path analysis with structural equation modeling (SEM) 
was used to estimate the model parameters using MPlus version 7. There was a small 
percentage (<1%) of missing data for the main study variables (symptom distress and 
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appraisals); among covariates, there was missing data among caregiver gender (<1%) and 
income (12%) variables. To account for missing data, full information maximum likelihood 
estimation (FIML) was utilized. All models included covariances between predictor 
variables, and covariances between error terms of patient and caregiver threat appraisals and 
efficacy variables.
Mediation effects were tested using the bootstrapping procedure in MPlus. Three fit indices 
were used to determine the adequacy of model fit: the comparative fit index (CFI), the root 
mean squared error of approximation (RMSEA), and the standardized root-mean-square 
residual (SRMR). The indicators of adequate model fit for these indices (i.e. the indication 
that the model fits the sample data well) are a CFI value of .90 or more; a RMSEA value of .
06 or less; a non-significant chi-square (χ2) value; and, a SRMR value of .08 or less [37]. 
The Bayesian Information Criterion (BIC) was used for model selection, with a difference in 
BIC values of greater than 10 very strong evidence that the model with the smaller BIC 
value is preferred [38].
Results
Table 2 provides means, standard deviations for symptom distress, threat appraisals, and 
self-efficacy variables and the correlations among these variables. Significant differences 
were found between patient and caregiver threat appraisals (p<.001) and symptom distress 
(p<.001). Two models were tested (unstandardized results presented in Figures 3 & 4, 
respectively). The model fit was good in the threat mediated model (CFI=1.00; RMSEA=.
000 (CI: 0.000, 0.043); χ2(16) = 16.26, p=0.3685; SRMR=.009) and the efficacy mediated 
model (CFI=1.00; RMSEA =.013 (CI: 0.000, 0.049); χ2(16) = 16.26, p=0.4351; SRMR=.
007). The efficacy mediated model had a lower BIC value (43821.492 vs. 43800.015), and a 
difference in values greater than 10 (BIC difference = 21.477), indicating that the efficacy 
mediated model is preferred. Thus, we focus the discussion of results on the efficacy 
mediated model (Figure 4).
H1. Symptoms→ threat. Supporting our hypothesis, holding all other variables constant, 
patients and caregivers higher in symptom distress were higher in threat appraisals (actor 
effects). Specifically, for every one unit increase in patient symptom distress, patient threat 
appraisals were expected to increase by .575 units (p<.001). Similarly, for every one unit 
increase in caregiver symptom distress, caregiver appraisals were expected to increase by .
853 units (p<.001). The second part of the hypothesis was partially supported. Holding all 
other variables constant, where caregivers were higher in symptom distress, patients were 
higher in threat appraisals (partner effect): a one unit increase in caregiver symptom distress 
was expected to result in a .201 unit increase in patient threat appraisals (p=.008).
H2. Symptom → efficacy. In line with the hypothesis, holding all other variables constant, 
patients and caregivers with higher symptom distress were lower in individual- and family-
related self-efficacy (actor effects). Specifically, for every one unit increase in patient 
symptom distress, patient individual self-efficacy was expected to decrease by 1.265 units 
(p<.001) and patient family-related self-efficacy was expected to decrease by .502 units (p<.
001). Similarly, for every one unit increase in caregiver symptom distress, caregiver 
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individual self-efficacy was expected to decrease by .899 units (p<.001), and caregiver 
family-related self-efficacy was expected to decrease by .308 units (p<.001). There was also 
a significant partner effect: holding all other variables constant, where patients were higher 
in symptom distress, caregiver family-related self-efficacy was lower. Specifically, for every 
one unit increase in patient symptom distress, caregiver family-related self-efficacy was 
expected to decrease by .154 units (p=.034).
H3. Efficacy → threat. As hypothesized, holding all other variables constant, patients and 
caregivers with higher individual-related self-efficacy were lower in threat appraisals (actor 
effects). For every one unit increase in patient individual self-efficacy, patient threat 
appraisals were expected to decrease by .170 units (p<.001); similarly, for every one unit 
increase in caregiver individual self-efficacy, caregiver threat appraisals were expected to 
decrease by .194 units (p<.001). However, neither patient nor caregiver family-related self-
efficacy were significantly associated with decreases in their own threat appraisals. In 
addition, there were no partner effects of self-efficacy on threat appraisals.
H4. Indirect effects of symptoms on threat. Patient symptom distress had a positive indirect 
effect on patient threat appraisals through patient individual self-efficacy (β=.215; 95% CI: 
0.117, .348). Caregiver symptom distress had a positive indirect effect on caregiver threat 
appraisals through caregiver individual self-efficacy (β=.175; 95% CI: 0.075, 0.318).
Discussion
The purpose of this study was to examine the influence of patient and caregiver symptom 
distress on their threat appraisals and their self-efficacy for coping with the illness 
(individual and family-related) in two competing models: one in which threat appraisals 
mediated the relationship between symptom distress and self-efficacy (threat mediated 
model), and another which in which self-efficacy mediated the relationship between 
symptom distress and threat appraisals (efficacy mediated model). Symptom distress was 
assessed for cancer (patients) and non-cancer related health problems (patients and 
caregivers). Symptom distress had direct effects on both dimensions of self-efficacy, and 
direct and indirect effects on threat appraisals. Results support self-efficacy as a mediator of 
the relationship between symptom distress and threat appraisals.
Supporting our hypothesis, patients and caregivers with more symptom distress appraised 
the cancer situation as more threatening and reported less individual and family-related self-
efficacy. This suggests that cancer-related symptoms and non-cancer related symptoms 
influence their appraisals about the cancer experience. In addition, more caregiver symptom 
distress was directly associated with higher patient threat appraisals, suggesting that 
caregivers' own health issues influence how threatening patients appraise their cancer 
situation. Tishelman and colleagues [39] describe the influence of symptom distress from 
both physical and psychological perspectives. Physically, the effects of the symptoms 
themselves could influence the extent to which patients appraise the cancer/caregiving 
situation as threatening and their assessment of their ability to manage the consequences of 
advanced cancer. Psychologically, the meanings the symptoms have for an individual also 
have importance. For example, patients' experience of symptoms could be perceived as 
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turning points in their health status or reminders of their current and future dependency on 
others [40]. Caregivers' experience of symptoms could be perceived as a consequence of 
providing care and a reminder of their own care needs.
Symptom distress also had indirect effects on threat appraisals. As a mediating factor, 
patient and caregiver individual self-efficacy helped to explain the relationship between their 
own symptom distress and threat appraisals (i.e., indirect effects). This suggests that the 
management of patient and caregiver symptoms may benefit their cancer-related cognitive 
appraisals. While a number of studies have reported how various domains of self-efficacy 
(e.g. general, symptom management, caregiving self-efficacy) predict symptom-related 
outcomes [41,42] this study contributes to the literature by demonstrating that cancer and 
non-cancer related symptoms are important predictors of cancer/caregiving-related self-
efficacy and that attention to patient and caregiver symptom distress could positively 
influence self-efficacy and threat related outcomes.
Furthermore, while symptom distress had indirect effects on threat appraisals, this indirect 
effect operated only through patients' and caregivers' own individual self-efficacy. This could 
be due to the fact that the items assessing threat appraisals were individual in nature (e.g., I 
feel that things are going to get worse for me). Future studies that examine this relationship 
should also include threat appraisals specifically related to the family. Evidence shows that 
cancer has a significant impact on the entire family system and despite their own needs, 
patients and caregivers provide support to others [22,43]. An important finding of this study 
is that their self-efficacy to do so was strongly influenced by their symptom distress. While 
much of the cancer literature has focused on how social support from family members 
influence patient and caregiver outcomes, more research is needed on how factors such 
symptom distress influence their capacity (self-efficacy) to help others.
Theory and research on self-efficacy often focuses on individual efforts [44]. Similarly, 
research on adults with advanced cancer and caregivers often conceptualize the “family” as 
represented by these two individuals. In reality, as noted by Bandura and colleagues [44], the 
dyad “is but one of the multiple interdependent subsystems operating within a family 
system.” Factors associated with family systems – including interdependence, support, 
alliances, and resources – likely influence an individual's own self-efficacy in various 
domains [44,45]. As such, aspects of the dyad and the broader family system likely affect 
the degree of individual and family-related self-efficacy reported by patients and caregivers 
in this study. This should be considered explicitly in future research. In addition, future 
studies may benefit from understanding the relationship between patient, caregiver and 
broader family members' individual self-efficacy and their collective family efficacy for 
coping with the disease, caregiving, and its consequences. Very little research has been done 
in this area [45]. Understanding these different types of efficacy will likely be useful to 
interventions focused on self and family-management of cancer and chronic conditions.
There are study limitations to consider. First, patients were asked to report about their cancer 
and non-cancer related symptoms. It would be useful to determine if patients' beliefs about 
the cause of the symptoms (i.e. cancer related or non-cancer related) influence their 
appraisal and self-efficacy. One of the challenges in collecting this information is that it can 
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often be difficult for individuals to determine a cause for symptoms where multimorbidity 
exists; however, it could be argued that what matters more is patient/caregiver perceptions of 
symptom origin. In addition, this study utilized cross-sectional data. Longitudinal 
investigations of the relationship between symptom distress and cognitive appraisals could 
highlight key points of transition and need throughout the trajectory of the advanced cancer 
experience. As mentioned above, our measure of threat appraisals included threat 
perceptions related to patients and caregivers as individuals (e.g., I feel that things are going 
to get worse for me) and not as a part of a family system (e.g., I feel that things are going to 
get worse for my family). Future studies should consider the inclusion of family-related 
threat appraisals. Lastly, there are a number of familial factors (e.g., family structure, 
communalism) that could influence relationships between the study variables and should be 
considered in future research. Despite these limitations, strengths of this study include the 
ability to recruit a relatively large sample of advanced cancer patient/caregiver dyads and the 
consideration of the health issues of both individuals.
Conclusions
This study suggests that the management of patients' and caregivers' symptoms are 
worthwhile intervention goals. While a number of successful pharmacological and 
behavioral interventions exist for improving symptom management for patients, many 
barriers to timely use of palliative care remain. Moreover, though caregiver assessment tools 
often take caregiver health into account, the use of caregiver assessment tools in practice is 
not consistent. Increased usage of patient palliative care, caregiver assessments, and 
supportive health care for family caregivers may be helpful for identifying the need for 
additional intervention and resources. Given the noted importance of cognitive appraisals in 
the stress and coping process, future research and interventions should take into account how 
the health concerns of both members of the dyad influence these factors.
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Figure 1. 
Threat Mediated Model Testing the Influence of Patient and Caregiver Symptom Distress on 
Threat Appraisals (Mediator) and Efficacy
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Figure 2. 
Efficacy Mediated Model Testing the Influence of Patient and Caregiver Symptom Distress 
on Self-Efficacy (Mediator) and Threat Appraisals
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Figure 3. 
Path Analysis Results: the Influence of Patient and Caregiver Symptom Distress on Threat 
Appraisals and Efficacy
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Figure 4. 
Path Analysis Results: the Influence of Patient and Caregiver Symptom Distress on Efficacy 
and Threat Appraisals
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Table 1
Patient and Caregiver Demographic Information
Patients (N=484) Caregivers (N=484) Difference Test
Age in years
 Mean (SD) 60.5(11.5) 56.5(13.4) p=.004a
 Range 26–95 18–88
Sex (%)
 Female 62.0 56.8 p=.237b
 Male 38.0 43.1
Race (%)
 American Indian/Alaskan Native 0.2 0 p=.589c
 Asian 1.0 1.2
 Black 15.3 15.9
 Pacific Islander 0.2 0
 White 79.3 79.6
 Multiracial 3.9 2.5
Highest level of education in years
 Mean (SD)a 14.5 (2.7) 14.6(2.8) p=.748a
Marital Status (%)
 Married/Living as married 75.6 82.9 p=.002c
 Divorced/Separated 13.2 8.1
 Widowed 6.0 2.3
 Never married 5.2 6.8
Relationship to patient (%; caregiver only) --
 Spouse -- 70.0
 Daughter -- 12.0
 Son -- 3.3
 Sister/Brother -- 0.2
 Other relative -- 5.6
 Friend -- 4.3
 Unknown/Coding error -- 4.5
Currently living with patient (caregiver only) --
 % Yes -- 82.6
a
Paired sample t-tests;
b
McNemar's Test;
cChi-Square Test.
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